Rigel Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 1.72 M | $48.87 M | 6.10% | 9.64% |
| VANGUARD GROUP INC | 11/07/2025 | 1.04 M | $29.55 M | -0.93% | 5.83% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 737.04 K | $20.88 M | 304.41% | 4.12% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 724.00 K | $20.51 M | -54.75% | 4.05% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 685.72 K | $19.41 M | 10.07% | 3.83% |
| MARSHALL WACE, LLP | 11/13/2025 | 601.33 K | $17.04 M | 62.99% | 3.36% |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 11/14/2025 | 591.55 K | $16.76 M | 0.00% | 3.31% |
| STATE STREET CORP | 11/14/2025 | 554.32 K | $15.70 M | -7.64% | 3.10% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 474.21 K | $13.43 M | 100.56% | 2.65% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 423.72 K | $12.01 M | 1.95% | 2.37% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 360.97 K | $10.23 M | 110.57% | 2.02% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 330.01 K | $9.35 M | -49.86% | 1.85% |
| JANE STREET GROUP, LLC | 11/14/2025 | 321.89 K | $9.12 M | 1,757.12% | 1.80% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 306.49 K | $8.68 M | 100.00% | 1.71% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 11/10/2025 | 284.39 K | $8.06 M | 8.52% | 1.59% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 230.72 K | $6.54 M | 100.00% | 1.29% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 228.40 K | $6.47 M | 54.13% | 1.28% |
| CM MANAGEMENT, LLC | 11/13/2025 | 225.00 K | $6.37 M | -10.00% | 1.26% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 220.30 K | $6.24 M | 474.56% | 1.23% |
| GLOBEFLEX CAPITAL L P | 11/12/2025 | 217.63 K | $6.17 M | 29.92% | 1.22% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 209.39 K | $5.93 M | 35.07% | 1.17% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 186.33 K | $5.28 M | 747.59% | 1.04% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 179.81 K | $5.09 M | 132.04% | 1.01% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 172.64 K | $4.89 M | 376.70% | 0.97% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 167.12 K | $4.73 M | 100.00% | 0.93% |
| PRUDENTIAL FINANCIAL INC | 11/13/2025 | 165.35 K | $4.68 M | 176.38% | 0.92% |
| BEACON HARBOR WEALTH ADVISORS, INC. | 11/05/2025 | 152.13 K | $4.31 M | 100.00% | 0.85% |
| MORGAN STANLEY | 11/14/2025 | 146.27 K | $4.14 M | -90.38% | 0.82% |
| NORTHERN TRUST CORP | 11/14/2025 | 137.70 K | $3.90 M | 0.88% | 0.77% |
| NUVEEN, LLC | 11/12/2025 | 133.47 K | $3.78 M | 29.24% | 0.75% |
| ZACKS INVESTMENT MANAGEMENT | 11/14/2025 | 128.23 K | $3.63 M | -5.60% | 0.72% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 117.99 K | $3.34 M | 616.93% | 0.66% |
| LSV ASSET MANAGEMENT | 11/06/2025 | 110.90 K | $3.14 M | 15.88% | 0.62% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 105.30 K | $2.98 M | 236.87% | 0.59% |
| UBS GROUP AG | 11/13/2025 | 100.60 K | $2.85 M | 47.82% | 0.56% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 97.86 K | $2.77 M | 5.19% | 0.55% |
| EMPIRE FINANCIAL MANAGEMENT COMPANY, LLC | 11/14/2025 | 89.51 K | $2.54 M | 280.90% | 0.50% |
| CITADEL ADVISORS LLC | 11/14/2025 | 86.46 K | $2.45 M | 100.00% | 0.48% |
| PACER ADVISORS, INC. | 10/15/2025 | 77.48 K | $2.20 M | 100.00% | 0.43% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 75.48 K | $2.14 M | -59.77% | 0.42% |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 11/13/2025 | 74.17 K | $2.10 M | -3.51% | 0.41% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 71.82 K | $2.06 M | 100.00% | 0.40% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 10/20/2025 | 69.07 K | $1.96 M | -16.12% | 0.39% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 61.77 K | $1.75 M | -3.21% | 0.35% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 60.83 K | $1.72 M | -38.46% | 0.34% |
| SEI INVESTMENTS CO | 11/13/2025 | 60.01 K | $1.70 M | 100.00% | 0.34% |
| FMR LLC | 11/13/2025 | 59.09 K | $1.67 M | 1,641.44% | 0.33% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 57.62 K | $1.63 M | 100.00% | 0.32% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 56.60 K | $1.60 M | 463.87% | 0.32% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10/29/2025 | 54.73 K | $1.55 M | 7.04% | 0.31% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rigel Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 221 institutional investors and hedge funds held shares of Rigel Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 1.72 M
VANGUARD GROUP INC: 1.04 M
GOLDMAN SACHS GROUP INC: 737,035
ARMISTICE CAPITAL, LLC: 724,000
ACADIAN ASSET MANAGEMENT LLC: 685,718
MARSHALL WACE, LLP: 601,333
83.81% of Rigel Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 33.19 M shares in the last 24 months. This purchase volume represents approximately $947.36 M in transactions.